Literature DB >> 10369792

Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study.

P Clausen1, B Feldt-Rasmussen, G Jensen, J S Jensen.   

Abstract

A slightly elevated urinary albumin excretion rate (UAER), above 5-10 microgram/min, is a predictor of atherosclerotic cardiovascular disease. Endothelial dysfunction is an important early feature of atherosclerosis. The plasma concentration of von Willebrand factor (vWF), a potential marker of endothelial dysfunction, predicts a subsequent increase of UAER in patients with diabetes. The aim of this study is to test the hypothesis that high concentrations of vWF as well as other haemostatic factors predict progression of UAER in clinically healthy subjects. UAER was measured together with selected markers of haemostatic function-vWF, tissue plasminogen activator (tPA), plasminogen activator inhibitor, factor VII and fibrinogen-in healthy volunteers aged 40-65 years. After a mean follow-up of 4.1 years, 64 of 74 agreed to a re-examination including re-measurement of UAER. Baseline vWF and tPA were both positively correlated to the change in UAER during follow-up (r=0.26, P=0.04 and r=0.40, P=0.001 respectively). The mean UAER increased significantly by 7.6 microgram/min and 7.5 microgram/min respectively in subjects with vWF and tPA above the medians at baseline (P=0.01 and P=0.003 respectively), whereas no changes in UAER were seen in subjects with vWF and tPA below the medians. Subjects with high tPA were also characterized by an excess of other cardiovascular risk factors at baseline. No significant differences in these risk factors were present between subjects with high or low vWF. High plasma concentrations of vWF and tPA are associated with progression of UAER in clinically healthy subjects. Both vWF and tPA are secreted by endothelial cells and the results suggest that endothelial dysfunction leads to progression of UAER.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369792

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study.

Authors:  C A Geluk; R A Tio; J G P Tijssen; R B van Dijk; W A Dijk; H L Hillege; P E de Jong; W H van Gilst; F Zijlstra
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

2.  Capillary Rarefaction Associates with Albuminuria: The Maastricht Study.

Authors:  Remy J H Martens; Ronald M A Henry; Alfons J H M Houben; Carla J H van der Kallen; Abraham A Kroon; Casper G Schalkwijk; Miranda T Schram; Simone J S Sep; Nicolaas C Schaper; Pieter C Dagnelie; Dennis M J Muris; Ed H B M Gronenschild; Frank M van der Sande; Karel M L Leunissen; Jeroen P Kooman; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2016-05-09       Impact factor: 10.121

3.  Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.

Authors:  Dimitrios Daoussis; Vasileios F Panoulas; Holly John; Tracey E Toms; Ioannis Antonopoulos; Gareth Treharne; Peter Nightingale; Karen M J Douglas; George D Kitas
Journal:  Clin Rheumatol       Date:  2010-04-16       Impact factor: 2.980

4.  Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.

Authors:  Bakhtawar K Mahmoodi; Ron T Gansevoort; Inger Anne Næss; Pamela L Lutsey; Sigrid K Brækkan; Nic J G M Veeger; Ellen E Brodin; Karina Meijer; Yingying Sang; Kunihiro Matsushita; Stein I Hallan; Jens Hammerstrøm; Suzanne C Cannegieter; Brad C Astor; Josef Coresh; Aaron R Folsom; John-Bjarne Hansen; Mary Cushman
Journal:  Circulation       Date:  2012-09-13       Impact factor: 29.690

5.  High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population.

Authors:  Aki Ashitani; Toshinori Ueno; Ayumu Nakashima; Shigehiro Doi; Kiminori Yamane; Takao Masaki
Journal:  Clin Exp Nephrol       Date:  2017-12-26       Impact factor: 2.801

6.  Higher levels of albuminuria within the normal range predict incident hypertension.

Authors:  John P Forman; Naomi D L Fisher; Emily L Schopick; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2008-06-25       Impact factor: 10.121

Review 7.  Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk.

Authors:  Cindy Lora Gil; Erika Hooker; Bruno Larrivée
Journal:  Kidney Med       Date:  2020-12-07

8.  Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure.

Authors:  Mary E Haas; Krishna G Aragam; Connor A Emdin; Alexander G Bick; Gibran Hemani; George Davey Smith; Sekar Kathiresan
Journal:  Am J Hum Genet       Date:  2018-09-13       Impact factor: 11.025

9.  Early Detection of Chronic Complications: Diabetic Nephropathy.

Authors:  Darko Černe
Journal:  EJIFCC       Date:  2002-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.